Director Share Dealings

RNS Number : 6942O

Futura Medical PLC

23 September 2013

 



For Immediate Release

23 September 2013

Futura Medical plc

("Futura" or "the Company")

Director Share Dealings

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that it has received notification of the following dealings which took place on 23 September 2013.

Derek Martin, Finance Director, exercised options over 100,000 new ordinary shares of 0.2p each in the Company at a price of 56.25 pence per share and sold 65,000 of the ordinary shares at a price of 70.00 pence per share to satisfy tax obligations and option exercise costs. On the same date Mr Martin gifted 35,000 ordinary shares to his wife, Julie Martin, at no cost, which were sold at a price of 70.00 pence per share.

Following the transactions the Director's holding in ordinary shares in the Company for the purposes of the AIM Rules for Companies is 280,000 shares (0.36% of the Company's issued share capital).

The 100,000 new ordinary shares issued raised £56,250 for the Company and shall rank pari passu with the existing issued ordinary shares of the Company.

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Cenkos Securities plc
Bobbie Hilliam	Tel:[phone]
For media enquiries please contact:
Buchanan
Mark Court / Fiona Henson / Sophie Cowles	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

RDSUOONROKAKUAR